General
Preferred name
CYTOSINE
Synonyms
6-Aminopyrimidin-2(1H)-one ()
4-Amino-2-hydroxypyrimidine ()
Cytosinimine ()
4-Amino-2-hydroxypyrimidine, Cytosinimine ()
NSC-27787 ()
Lamivudine impurity c rs ()
Lamivudine impurity c ()
Cytosine-d2 ()
Cytosine-13C,15N2 ()
P&D ID
PD013768
CAS
118511-36-7
71-30-7
106391-24-6
181517-10-2
Tags
available
drug candidate
Drug Status
investigational
Max Phase
2.0
Drug indication
acute lymphoblastic leukemia
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Cytosine is one of the four main bases found in DNA and RNA. Cytosine modifications exhibit circadian oscillations that are involved in epigenetic diversity and aging. Cytosine can be used in cancer research[1][2][3][4].
PRICE 29
DESCRIPTION Cytosine (6-Aminopyrimidin-2(1H)-one) is a pyrimidine base that is a fundamental unit of nucleic acids. The deamination of cytosine alone is apparent and the nucleotide of cytosine is the prime mutagenic nucleotide in leukaemia and cancer. (TargetMol Bioactive Compound Library)
Compound Sets
11
Cayman Chemical Bioactives
ChEMBL Drugs
Concise Guide to Pharmacology 2017/18
Concise Guide to Pharmacology 2019/20
Concise Guide to Pharmacology 2021/22
Concise Guide to Pharmacology 2023/24
Guide to Pharmacology
MedChem Express Bioactive Compound Library
NPC Screening Collection
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
External IDs
55
Properties
(calculated by RDKit )
Molecular Weight
111.04
Hydrogen Bond Acceptors
3
Hydrogen Bond Donors
2
Rotatable Bonds
0
Ring Count
1
Aromatic Ring Count
1
cLogP
-0.65
TPSA
71.77
Fraction CSP3
0.0
Chiral centers
0.0
Largest ring
6.0
QED
0.47
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
Endogenous Metabolite
Pathway
Metabolism
Metabolic Enzyme/Protease
Source data